KKR

Kohlberg Kravis Roberts is a global investment firm that manages a diverse range of alternative asset classes, including private equity, energy, infrastructure, real estate, credit, and hedge funds through strategic partnerships. Founded in 1976 by Jerome Kohlberg, Jr., Henry Kravis, and George R. Roberts, the firm has completed numerous notable transactions, including the leveraged buyout of RJR Nabisco and TXU. KKR employs a disciplined investment approach aimed at generating attractive returns for its fund investors while investing its own capital alongside that of its clients. The firm's extensive operations span 21 cities across 16 countries, with its headquarters currently located in New York. KKR also offers comprehensive human resources services, further diversifying its business capabilities.

Joseph Y. Bae

Co-President and Co-Chief Operating Officer

Todd Builione

Member, President of KKR Credit

Mattia Caprioli

Partner, Co-Head of European Private Equity

Suzanne O. Donohoe

Partner and Global Head of Strategic Growth

Tim Franks

Partner

Brandon Freiman

Partner and Head of North American Infrastructure

Philipp Freise

Partner, Co-Head of European Private Equity

Chris Harrington

Partner

David Kerko

Director

David Lang

Partner

Vincent Letteri

Managing Director, TMT Growth Equity

Ming Lu

Head of Asia Pacific

Henry H. McVey

Member & Head of Global Macro and Asset Allocation

Roger Morales

Partner, Head of Commercial Real Estate Acquisitions

Winnie Wutte

Director, Client and Partner Group

Ryan L.G. Wilson

Director, Credit

Past deals in North Carolina

Northumbrian Water

Secondary Market in 2022
Northumbrian Water Limited is a water company in the United Kingdom, providing mains water and sewerage services in the English counties of Northumberland, Tyne and Wear, Durham and parts of North Yorkshire, and also supplying water as Essex and Suffolk Water.

Epic Games

Venture Round in 2021
Epic Games, Inc. is an American video game and software company based in Cary, North Carolina. Founded in 1991, the company develops and creates games for various platforms, including PCs, consoles, mobile devices, artificial reality, and virtual reality. In addition to its own game development, Epic Games offers its game engine technology to other developers, enabling them to create high-fidelity, interactive experiences. The company also operates a game store that supports independent developers in producing quality games and 3D content. Originally known as Epic MegaGames, Inc., the company rebranded to Epic Games, Inc. in March 1999.

Flow Control Group

Acquisition in 2021
Flow Control Group serves a key role in providing mission-critical, complementary products enabling customers to operate their manufacturing facilities efficiently and effectively.

Chili Technology

Private Equity Round in 2020
ChiliSleep is a sleep technology brand focused on the future of sleep-driven health. As the original inventors of the world’s first hydro-powered, temperature-regulated sleep system backed by 10+ years of sleep research and with over a dozen patents pending, ChiliSleep is revolutionizing the way the world sleeps. ChiliSleep’s award-winning sleep solutions chiliPAD™ and OOLER® consistently outperform the competition in the cooling/warming mattress topper category.

Epic Games

Venture Round in 2020
Epic Games, Inc. is an American video game and software company based in Cary, North Carolina. Founded in 1991, the company develops and creates games for various platforms, including PCs, consoles, mobile devices, artificial reality, and virtual reality. In addition to its own game development, Epic Games offers its game engine technology to other developers, enabling them to create high-fidelity, interactive experiences. The company also operates a game store that supports independent developers in producing quality games and 3D content. Originally known as Epic MegaGames, Inc., the company rebranded to Epic Games, Inc. in March 1999.

Epic Games

Private Equity Round in 2020
Epic Games, Inc. is an American video game and software company based in Cary, North Carolina. Founded in 1991, the company develops and creates games for various platforms, including PCs, consoles, mobile devices, artificial reality, and virtual reality. In addition to its own game development, Epic Games offers its game engine technology to other developers, enabling them to create high-fidelity, interactive experiences. The company also operates a game store that supports independent developers in producing quality games and 3D content. Originally known as Epic MegaGames, Inc., the company rebranded to Epic Games, Inc. in March 1999.

Epic Games

Venture Round in 2018
Epic Games, Inc. is an American video game and software company based in Cary, North Carolina. Founded in 1991, the company develops and creates games for various platforms, including PCs, consoles, mobile devices, artificial reality, and virtual reality. In addition to its own game development, Epic Games offers its game engine technology to other developers, enabling them to create high-fidelity, interactive experiences. The company also operates a game store that supports independent developers in producing quality games and 3D content. Originally known as Epic MegaGames, Inc., the company rebranded to Epic Games, Inc. in March 1999.

Cohera Medical

Venture Round in 2015
Cohera Medical, Inc. is a medical device company based in Raleigh, North Carolina, specializing in the development and commercialization of surgical adhesives and sealants for various surgical applications. Founded in 2003, the company’s lead product, TissuGlu, is a biocompatible surgical adhesive designed for approximating tissue planes in procedures such as abdominoplasty, with additional approvals in Europe for use in surgeries involving large flap reconstructions. Cohera Medical also develops Sylys, a synthetic surgical sealant aimed at reducing anastomotic leaks in gastrointestinal surgeries, which has received CE Mark approval for specific applications. The company’s innovative products utilize a unique chemical design that is resorbable and non-toxic, facilitating strong bonding between tissue layers. Cohera Medical continues to expand its product pipeline, which includes surgical mesh adhesives, hemostatic foams, and other wound management solutions, although many products are currently available only for investigational use and have not yet received FDA approval.

Arbor Pharmaceuticals

Private Equity Round in 2014
Arbor Pharmaceuticals, operates as a specialty pharmaceutical company focusing on pediatric medicine. It engages in licensing, developing, and commercializing late-stage products for common pediatric conditions. The company's products include ZINOTIC and ZINOTIC ES, which addresses Acute Otitis Externa; NEOTIC, an otic analgesic agent for the treatment of pain and inflammation associated with Acute Otitis Media; and XYLAREX for the dietary management of Recurrent Acute Otitis Media. Its products also include Pediaderm HC Complete Kit, which is specifically developed to treat, manage, and protect the skin of children with atopic dermatitis, commonly referred to as eczema. The company markets its products specialty sales forces in the United States. Arbor Pharmaceuticals, was founded in 2006 and is based in Raleigh, North Carolina.

PRA International

Acquisition in 2013
PRA International, a prominent contract research organization (CRO) headquartered in Raleigh, North Carolina, specializes in providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two main segments: Clinical Research and Data Solutions. The Clinical Research segment encompasses a range of services, including clinical trial management, regulatory affairs, biostatistics, and quality assurance, supporting all phases of drug development. Additionally, PRA offers strategic solutions such as embedded services and early development services for Phase I and II studies. The Data Solutions segment focuses on delivering data analytics, technology, and consulting services, providing clients with insights into market intelligence and commercial effectiveness. With over 10,000 employees operating in more than 80 countries, PRA has contributed to the successful development of numerous marketed drugs, conducting pivotal trials that have led to regulatory approvals. The company has also partnered with organizations like The Leukemia & Lymphoma Society to advance clinical research for specific diseases. Founded in 1976, PRA International has established itself as a leader in the global clinical research landscape.